Treatment Resistant Depression 

The Object of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone (ClinicalTrals.gov, 2019)

18-65

III

NCT03739203

Clinical Trial #

Phase

Age Group

Major Depressive Disorder

An open-label, long-term, safety study of AXS-05 in patients with major depressive disorder (MDD), including treatment resistant depression. (ClinicalTrials.gov, 2019)

18-65

Open-Label

 NCT04039022

Clinical Trial #

Phase

Age Group

Endometriosis

The purpose of this study is to assess the safety and efficacy of MT-2990 for treatment of moderate to severe endometriosis-related pain in women with surgically diagnosed endometriosis. (ClinicalTrials.gov, 2019)

18-49

II

 NCT03840993

Clinical Trial #

Phase

Age Group

Borderline Personality Disorder

There are currently no pharmacological treatments approved to treat borderline personality disorder (BPD). This trial will be conducted to evaluate the efficacy and safety of brexpiprazole for the treatment of subjects diagnosed with BPD to provide a pharmacological treatment for BPD.(ClinicalTrials.gov, 2019)

18-65

II

NCT04100096

Clinical Trial #

Phase

Age Group

Post Traumatic Stress Disorder

This will be a 12-week, multicenter, randomized, double-blind trial evaluating the efficacy, safety, and tolerability of fixed-dose brexpiprazole + sertraline combination treatment in adult subjects with post-traumatic stress disorder. (ClinicalTrials.gov, 2019)

18-65

III

NCT04174170

Clinical Trial #

Phase

Age Group

Tourette Syndrome

This study evaluates the effect of ecopipam tablets in children and adolescents in the treatment of Tourette's Syndrome (TS). Half of the participants will receive ecopipam tablets, while the other half will receive matching placebo tablets. (ClinicalTrals.gov, 2019)

6-17

II

NCT04007991

Clinical Trial #

Phase

Age Group

Tourette Syndrome

To evaluate the long-term efficacy of oral aripiprazole in pediatric subjects for the treatment of Tourette's Disorder (TD) (ClinicalTrals.gov, 2019)

6-17

IIII

NCT03661983

Clinical Trial #

Phase

Age Group

  • White Facebook Icon
  • White Instagram Icon
  • White YouTube Icon
440.234.5700 | info@northstarresearch.org | 18660 Bagley Road, Building II, Suite 205 Middleburg Heights, OH 44130

© 2019 North Star Medical in corporation with Wix.com